- Home
- TNGX vs MVIS Comparison
TNGX vs MVIS Comparison
Compare TNGX & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MVIS
- Stock Information
- Founded
- TNGX 2014
- MVIS 1993
- Country
- TNGX United States
- MVIS United States
- Employees
- TNGX N/A
- MVIS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MVIS Industrial Machinery/Components
- Sector
- TNGX Health Care
- MVIS Technology
- Exchange
- TNGX Nasdaq
- MVIS Nasdaq
- Market Cap
- TNGX 351.2M
- MVIS 281.7M
- IPO Year
- TNGX N/A
- MVIS 1996
- Fundamental
- Price
- TNGX $5.65
- MVIS $1.11
- Analyst Decision
- TNGX Strong Buy
- MVIS Buy
- Analyst Count
- TNGX 6
- MVIS 4
- Target Price
- TNGX $12.20
- MVIS $2.50
- AVG Volume (30 Days)
- TNGX 4.0M
- MVIS 7.6M
- Earning Date
- TNGX 08-06-2025
- MVIS 08-06-2025
- Dividend Yield
- TNGX N/A
- MVIS N/A
- EPS Growth
- TNGX N/A
- MVIS N/A
- EPS
- TNGX N/A
- MVIS N/A
- Revenue
- TNGX $40,990,000.00
- MVIS $4,329,000.00
- Revenue This Year
- TNGX N/A
- MVIS $508.18
- Revenue Next Year
- TNGX N/A
- MVIS $86.32
- P/E Ratio
- TNGX N/A
- MVIS N/A
- Revenue Growth
- TNGX 10.09
- MVIS N/A
- 52 Week Low
- TNGX $1.03
- MVIS $0.80
- 52 Week High
- TNGX $12.02
- MVIS $1.95
- Technical
- Relative Strength Index (RSI)
- TNGX 76.88
- MVIS 47.00
- Support Level
- TNGX $4.80
- MVIS $1.08
- Resistance Level
- TNGX $5.63
- MVIS $1.19
- Average True Range (ATR)
- TNGX 0.55
- MVIS 0.09
- MACD
- TNGX -0.03
- MVIS -0.01
- Stochastic Oscillator
- TNGX 80.13
- MVIS 15.63
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.